z-logo
open-access-imgOpen Access
The Role ofKlebsiellain Crohn’s Disease with a Potential for the Use of Antimicrobial Measures
Author(s) -
Taha Rashid,
Alan Ebringer,
Clyde Wilson
Publication year - 2013
Publication title -
international journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.8
H-Index - 33
eISSN - 1687-9279
pISSN - 1687-9260
DOI - 10.1155/2013/610393
Subject(s) - antibiotics , klebsiella , antimicrobial , crohn's disease , disease , immune system , microbiology and biotechnology , medicine , antibody , bacteria , pathological , immunology , biology , escherichia coli , biochemistry , genetics , gene
There is a general consensus that Crohn's disease (CD) develops as the result of immune-mediated tissue damage triggered by infections with intestinal microbial agents. Based on the results of existing microbiological, molecular, and immunological studies, Klebsiella microbe seems to have a key role in the initiation and perpetuation of the pathological damage involving the gut and joint tissues in patients with CD. Six different gastroenterology centres in the UK have reported elevated levels of antibodies to Klebsiella in CD patients. There is a relationship between high intake of starch-containing diet, enhanced growth of gut microbes, and the production of pullulanases by Klebsiella . It is proposed that eradication of these microbes by the use of antibiotics and low starch diet, in addition to the currently used treatment, could help in alleviating or halting the disease process in CD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom